Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Nov 18, 2025
Transactions
15
Purchases
2
Sales
13
Purchase value
$5.74M
Sale value
$3.79M
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
Brian N CherryDirector
4
Filed Sep 4, 2026Period of report Sep 4, 20260000905148-26-004085
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseSep 4, 2026
Common StockF1
104,166
$9.60
$999.99K
166,486
Direct
Filing footnotes · 1
F1Represents shares purchased by the Reporting Person from the Issuer, through its sales agent, pursuant to that certain Sales Agreement, dated November 1, 2023, by and between the Issuer and TD Securities (USA) LLC.
Filed Aug 26, 2026Period of report Aug 17, 20260000905148-26-003960
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 17, 2026
Common StockF1F2
5,062
$8.0764
$40.88K
132,775
Direct
Filing footnotes · 2
F1Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 17, 2026, on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
Filed May 20, 2026Period of report May 18, 20260000905148-26-002571
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 18, 2026
Common StockF1F2
5,241
$9.1289
$47.84K
137,837
Direct
Filing footnotes · 2
F1Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2Represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $9.12 to $9.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Filed May 20, 2026Period of report May 18, 20260000905148-26-002570
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 18, 2026
Common StockF1F2
2,414
$9.1286
$22.04K
49,636
Direct
Filing footnotes · 2
F1Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2Represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $9.12 to $9.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Filed May 11, 2026Period of report May 7, 20260001193125-26-217380
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 7, 2026
Common StockF1F2F3
313,446
$10.0975
$3.17M
1,011,000
IndirectSee Footnote
Filing footnotes · 4
F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.50, inclusive. The Reporting Person undertake to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F2Represents securities held by Panacea Venture Healthcare Fund II, L.P.
F3James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. ("Fund II GP") and Panacea Opportunity Fund I GP Company, Ltd. ("Opportunity Fund GP"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership.
F4Represents securities held by Panacea Opportunity Fund I, L.P.
Filed May 11, 2026Period of report May 7, 20260000935836-26-000239
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseMay 7, 2026
Common StockF2F3F4F1
507,407
$9.35
$4.74M
1,552,000
IndirectSee Note
Filing footnotes · 4
F1The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controller owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The reporting persons are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The reporting persons disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein.
F2Qualified Fund purchased 474,780 of the shares puchased in this transaction.
F3The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.85 to $9.39 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F4After this transaction, Qualified Fund held 1,445,609 shares of the Issuer's Common Stock.
Filed Mar 4, 2026Period of report Mar 2, 20260000905148-26-001144
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF1F2F3
24
$5.077
$121.85
33,830
Direct
SaleMar 2, 2026
Common StockF1F2
1,603
$5.081
$8.14K
32,227
Direct
SaleMar 2, 2026
Common StockF1F2
377
$5.082
$1.92K
31,850
Direct
SaleMar 2, 2026
Common StockF1F2
100
$5.083
$508.30
31,750
Direct
Filing footnotes · 3
F1Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2026 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
F3This amount includes 400 shares purchased under the Issuer's Employee Stock Purchase Plan on November 28, 2025.
Filed Mar 4, 2026Period of report Mar 2, 20260000905148-26-001143
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF1F2
198
$5.079
$1.01K
64,776
Direct
SaleMar 2, 2026
Common StockF1F2
58
$5.08
$294.64
64,718
Direct
SaleMar 2, 2026
Common StockF1F2
1,298
$5.086
$6.60K
63,420
Direct
SaleMar 2, 2026
Common StockF1F2
1,442
$5.087
$7.34K
61,978
Direct
Filing footnotes · 2
F1Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2026 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
Filed Jan 14, 2026Period of report Jan 12, 20260001193125-26-013358
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 12, 2026
Common StockF3F1F2
80,554
$6.0707
$489.02K
1,324,446
IndirectSee Footnotes
Filing footnotes · 4
F1Represents securities held by Panacea Venture Healthcare Fund II, L.P.
F2James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. ("Fund II GP") and Panacea Opportunity Fund I GP Company, Ltd. ("Opportunity Fund GP"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $5.9888 to $6.2838, inclusive. The Reporting Person undertake to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4Represents securities held by Panacea Opportunity Fund I, L.P.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.